Endo International (NASDAQ:ENDP) reported Q1 EPS of $0.66, $0.20 better than the analyst estimate of $0.46. Revenue for the quarter came in at $652 million versus the consensus estimate of $631.07 million.
GUIDANCE:
Endo International sees Q2 2022 EPS of ($0.17)-($0.15), versus the consensus of $0.48. Endo International sees Q2 2022 revenue of $550-525 million, versus the consensus of $655.6 million.